First patient treated in global strategic collaboration between Cydar Medical and Medtronic


Cydar MedicalCydar Medical has announced the successful treatment of the first patient in a strategic collaboration with Medtronic. The collaboration, which spans 40 sites across the USA, UK and Europe, involves the integration of the company’s Cydar Maps software with Medtronic’s services and case support, with the aim of improving patient care and the efficiency of medical professionals by introducing unique artificial intelligence (AI) solutions into the clinical environment.

The first patient in the pilot programme was treated using Cydar Maps at Edward Hospital (Naperville, USA) by vascular and endovascular surgeon George Pontikis.

Cydar Maps is the first product from Cydar’s AI technology platform and, according to the company, transforms the way information is provided to clinicians undertaking image-guided minimally invasive surgery (MIS) simplifying complexities within operating theatres at leading hospitals across the globe.

The company explains that Cydar Maps generates a 3D map of patient soft tissue to support and integrate preoperative planning, intraoperative guidance and postoperative review of endovascular MIS, using AI to update the map throughout the patient journey. Cydar Maps has been shown to offer a number of benefits, a company press release reports, including halving the radiation exposure for patients and the clinical team, simplifying the clinical workflow and increasing clinician confidence, which in turn can significantly reduce procedure times.

The pilot programme is also expected to inform the ongoing development of Cydar Maps, which will include predictive analytics to support optimised procedure planning based on the use of AI to compare patient anatomy and procedure outcomes from a global data set.

Pontikis said: “This cutting-edge technology empowers us with the ability to navigate complex vascular procedures with greater precision—ensuring optimal outcomes for our patients. We are honoured to be a part of this innovative program and are eager to contribute to the advancement of endovascular aortic surgery.”

Paul Mussenden, chief executive officer of Cydar Medical, commented: “This is an important milestone for Cydar, to be working with Medtronic to accelerate the adoption of our AI-solution by the global endovascular community,” said Paul Mussenden, CEO of Cydar. “The goal is to provide clinicians with a more predictable and efficient way to perform minimally invasive image-guided procedures. We look forward to supporting the treatment of additional patients across the planned 40 sites and to continue the introduction of the exciting product developments we have planned over the course of the year ahead.”


Please enter your comment!
Please enter your name here